Clinical Trial Update: Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pevonedistat plus azacitidine as maintenance therapy after allogeneic stem cell transplantation in non-remission acute myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Pevonedistat (pevonedistat)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: TERMINATED | Results posted: 2020-10-29